Authors: Uram Ł; Faculty of Chemistry, Rzeszów University of Technology, 6 Powstańcow Warszawy Ave., 35-959 Rzeszów, Poland., Wróbel K; Medical College, Rzeszów University, 1a Warzywna Street, 35-310 Rzeszów, Poland., Walczak M; Faculty of Chemistry, Rzeszów University of Technology, 6 Powstańcow Warszawy Ave., 35-959 Rzeszów, Poland., Szymaszek Ż; Faculty of Chemistry, Rzeszów University of Technology, 6 Powstańcow Warszawy Ave., 35-959 Rzeszów, Poland., Twardowska M; Faculty of Chemistry, Rzeszów University of Technology, 6 Powstańcow Warszawy Ave., 35-959 Rzeszów, Poland., Wołowiec S; Medical College, Rzeszów University, 1a Warzywna Street, 35-310 Rzeszów, Poland.

Source: Molecules (Basel, Switzerland) [Molecules] 2023 Aug 30; Vol. 28 (17). Date of Electronic Publication: 2023 Aug 30.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049 (Electronic) Linking ISSN: 14203049 NLM ISO Abbreviation: Molecules Subsets: MEDLINE

Authors: Simigdala N; Biomedical Research Foundation Academy of Athens, Athens, Greece. nsimigdala@bioacademy.gr., Chalari A; Biomedical Research Foundation Academy of Athens, Athens, Greece., Sklirou AD; Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece., Chavdoula E; Biomedical Research Foundation Academy of Athens, Athens, Greece.; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.; The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH, USA., Papafotiou G; Biomedical Research Foundation Academy of Athens, Athens, Greece., Melissa P; Biomedical Research Foundation Academy of Athens, Athens, Greece., Kafalidou A; Biomedical Research Foundation Academy of Athens, Athens, Greece., Paschalidis N; Biomedical Research Foundation Academy of Athens, Athens, Greece., Pateras IS; 2nd Department of Pathology, Medical School, 'Attikon' University Hospital, National and Kapodistrian University of Athens, Athens, Greece., Athanasiadis E; Biomedical Research Foundation Academy of Athens, Athens, Greece., Konstantopoulos D; Institute for Fundamental Biomedical Research, BSRC 'Alexander Fleming', 16672, Vari, Greece., Trougakos IP; Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece., Klinakis A; Biomedical Research Foundation Academy of Athens, Athens, Greece. aklinakis@bioacademy.gr.

Source: Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2023 Mar 18; Vol. 80 (4), pp. 100. Date of Electronic Publication: 2023 Mar 18.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: Switzerland NLM ID: 9705402 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-9071 (Electronic) Linking ISSN: 1420682X NLM ISO Abbreviation: Cell Mol Life Sci Subsets: MEDLINE

MeSH Terms: Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , DNA-Binding Proteins*/genetics , Lapatinib*/pharmacology , Mitochondria*/pathology, Animals ; Female ; Humans ; Mice ; Cell Transformation, Neoplastic/genetics ; Genes, Tumor Suppressor ; Mice, Knockout ; Epithelial-Mesenchymal Transition

Authors: Gulmez A; Department of Medical Oncology, Inonu University, Malatya, Turkey.

Source: Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Apr; Vol. 19 (Supplement), pp. S0.

Publication Type: Case Reports

Journal Info: Publisher: Medknow Publications Country of Publication: India NLM ID: 101249598 Publication Model: Print Cited Medium: Internet ISSN: 1998-4138 (Electronic) Linking ISSN: 19984138 NLM ISO Abbreviation: J Cancer Res Ther Subsets: MEDLINE

Authors: Normann LS; Department of Research and Innovation, Vestre Viken Hospital Trust, Drammen, Norway.; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Medical Genetics, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway., Haugen MH; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Hongisto V; Division of Toxicology, Misvik Biology, Turku, Finland., Aure MR; Department of Medical Genetics, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway., Leivonen SK; Applied Tumor Genomics Research Program, Medical Faculty, University of Helsinki, Helsinki, Finland., Kristensen VN; Department of Medical Genetics, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway., Tahiri A; Department of Research and Innovation, Vestre Viken Hospital Trust, Drammen, Norway., Engebraaten O; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Sahlberg KK; Department of Research and Innovation, Vestre Viken Hospital Trust, Drammen, Norway.; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Mælandsmo GM; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute for Medical Biology, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway.

Source: PloS one [PLoS One] 2023 Jan 27; Vol. 18 (1), pp. e0280507. Date of Electronic Publication: 2023 Jan 27 (Print Publication: 2023).

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Authors: Gaymon DO; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States of America., Barndt R; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States of America., Stires H; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States of America., Riggins RB; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States of America., Johnson MD; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States of America.

Source: PloS one [PLoS One] 2023 Jan 30; Vol. 18 (1), pp. e0267492. Date of Electronic Publication: 2023 Jan 30 (Print Publication: 2023).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Authors: Lee C; Department of Biological Sciences, College of Information and Biotechnology, Ulsan National Institute of Science and Technology, Ulsan, 44919, Republic of Korea., Kim M; Department of Biological Sciences, College of Information and Biotechnology, Ulsan National Institute of Science and Technology, Ulsan, 44919, Republic of Korea., Park C; Department of Biological Sciences, College of Information and Biotechnology, Ulsan National Institute of Science and Technology, Ulsan, 44919, Republic of Korea., Jo W; Department of Biological Sciences, College of Information and Biotechnology, Ulsan National Institute of Science and Technology, Ulsan, 44919, Republic of Korea., Seo JK; UNIST Central Research Facility, Ulsan National Institute of Science and Technology, Ulsan, 44919, Republic of Korea., Kim S; Department of Biological Sciences, College of Information and Biotechnology, Ulsan National Institute of Science and Technology, Ulsan, 44919, Republic of Korea., Oh J; Department of Biological Sciences, College of Information and Biotechnology, Ulsan National Institute of Science and Technology, Ulsan, 44919, Republic of Korea., Kim CS; Department of Biological Sciences, College of Information and Biotechnology, Ulsan National Institute of Science and Technology, Ulsan, 44919, Republic of Korea., Ryu HS; Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea., Lee KH; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University, Seoul, Republic of Korea., Park J; Department of Biological Sciences, College of Information and Biotechnology, Ulsan National Institute of Science and Technology, Ulsan, 44919, Republic of Korea. jpark@unist.ac.kr.

Source: Nature communications [Nat Commun] 2023 Jan 27; Vol. 14 (1), pp. 439. Date of Electronic Publication: 2023 Jan 27.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Authors: Harada Y; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.; Graduate School of Medicine, Kyoto University, 53 Shogoin-Kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan., Sato A; Department of Clinical Laboratory Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan., Nakamura H; Department of Transfusion Medicine, Saga University Hospital, 5-1-1 Nabeshima, Saga, 849-8501, Japan., Kai K; Department of Pathology, Saga University Hospital, 5-1-1 Nabeshima, Saga, 849-8501, Japan., Kitamura S; Department of Pathology, Saga University Hospital, 5-1-1 Nabeshima, Saga, 849-8501, Japan., Nakamura T; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan., Kurihara Y; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan., Ikeda S; Department of Precision Cancer Medicine, Center for Innovative Cancer Treatment, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan., Sueoka E; Department of Clinical Laboratory Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan., Kimura S; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan., Sueoka-Aragane N; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan. sueokan@cc.saga-u.ac.jp.

Source: BMC cancer [BMC Cancer] 2023 Jan 23; Vol. 23 (1), pp. 77. Date of Electronic Publication: 2023 Jan 23.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Authors: Yuan Y; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China., Liu X; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China., Cai Y; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China., Li W; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Source: PloS one [PLoS One] 2023 Jan 05; Vol. 18 (1), pp. e0279775. Date of Electronic Publication: 2023 Jan 05 (Print Publication: 2023).

Publication Type: Systematic Review; Meta-Analysis; Journal Article

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Authors: Aoyama J; Department of Biology and Function in Head and Neck, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Nojima Y; Department of Biology and Function in Head and Neck, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Sano D; Department of Biology and Function in Head and Neck, Yokohama City University Graduate School of Medicine, Yokohama, Japan.; Department of Otorhinolaryngology-Head and Neck Surgery, Yokohama City University, School of Medicine, Yokohama, Japan., Hirai Y; Department of Biology and Function in Head and Neck, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Kijima N; Department of Biology and Function in Head and Neck, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Aizawa Y; Department of Biology and Function in Head and Neck, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Takada K; Department of Biology and Function in Head and Neck, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Hatano T; Department of Biology and Function in Head and Neck, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Takahashi H; Department of Biology and Function in Head and Neck, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Nishimura G; Department of Biology and Function in Head and Neck, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Oridate N; Department of Biology and Function in Head and Neck, Yokohama City University Graduate School of Medicine, Yokohama, Japan.; Department of Otorhinolaryngology-Head and Neck Surgery, Yokohama City University, School of Medicine, Yokohama, Japan.

Source: Head & neck [Head Neck] 2023 Jul; Vol. 45 (7), pp. 1801-1811. Date of Electronic Publication: 2023 May 15.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: John Wiley And Sons Country of Publication: United States NLM ID: 8902541 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0347 (Electronic) Linking ISSN: 10433074 NLM ISO Abbreviation: Head Neck Subsets: MEDLINE

MeSH Terms: Salivary Gland Neoplasms*/genetics , Carcinoma, Ductal*/metabolism, Humans ; Animals ; Mice ; Lapatinib/pharmacology ; Lapatinib/metabolism ; Lapatinib/therapeutic use ; Salivary Ducts/pathology ; Receptor, ErbB-2/genetics ; Signal Transduction

Authors: García-Lainez G; Instituto de Investigación Sanitaria (IIS) La Fe, Hospital Universitari i Politècnic La Fe, Avenida de Fernando Abril Martorell 106, 46026, Valencia, Spain., Vayá I; Departamento de Química-Instituto de Tecnología Química UPV-CSIC, Universitat Politècnica de València, Camino de Vera s/n, 46022, Valencia, Spain.; Unidad Mixta de Investigación UPV-Instituto de Investigación Sanitaria (IIS) La Fe, Hospital Universitari i Politècnic La Fe, Avenida de Fernando Abril Martorell 106, 46026, Valencia, Spain., Marín MP; Instituto de Investigación Sanitaria (IIS) La Fe, Hospital Universitari i Politècnic La Fe, Avenida de Fernando Abril Martorell 106, 46026, Valencia, Spain., Miranda MA; Departamento de Química-Instituto de Tecnología Química UPV-CSIC, Universitat Politècnica de València, Camino de Vera s/n, 46022, Valencia, Spain. mmiranda@qim.upv.es.; Unidad Mixta de Investigación UPV-Instituto de Investigación Sanitaria (IIS) La Fe, Hospital Universitari i Politècnic La Fe, Avenida de Fernando Abril Martorell 106, 46026, Valencia, Spain. mmiranda@qim.upv.es., Andreu I; Departamento de Química-Instituto de Tecnología Química UPV-CSIC, Universitat Politècnica de València, Camino de Vera s/n, 46022, Valencia, Spain. iandreur@qim.upv.es.; Unidad Mixta de Investigación UPV-Instituto de Investigación Sanitaria (IIS) La Fe, Hospital Universitari i Politècnic La Fe, Avenida de Fernando Abril Martorell 106, 46026, Valencia, Spain. iandreur@qim.upv.es.

Source: Archives of toxicology [Arch Toxicol] 2021 Jan; Vol. 95 (1), pp. 169-178. Date of Electronic Publication: 2020 Aug 19.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0417615 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0738 (Electronic) Linking ISSN: 03405761 NLM ISO Abbreviation: Arch Toxicol Subsets: MEDLINE

Transliterated Title: Traitements systémiques ciblés et radiothérapie locorégionale pour les cancers du sein : peut-on espérer un bénéfice de la potentialisation du traitement local ?

Authors: Camps Maléa A; Service de radiothérapie, centre Henry-S-Kaplan, CHRU Bretonneau, Tours, France., Hennequin C; Service de cancérologie-radiothérapie, hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75475 Paris, France., Rivera S; Département d'oncologie-radiothérapie, institut Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif, France. Electronic address: sofia.rivera@gustaveroussy.fr.

Source: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [Cancer Radiother] 2023 Sep; Vol. 27 (6-7), pp. 535-541. Date of Electronic Publication: 2023 Aug 07.

Publication Type: English Abstract; Journal Article; Review

Journal Info: Publisher: Elsevier Country of Publication: France NLM ID: 9711272 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1769-6658 (Electronic) Linking ISSN: 12783218 NLM ISO Abbreviation: Cancer Radiother Subsets: MEDLINE

MeSH Terms: Breast Neoplasms*/radiotherapy , Breast Neoplasms*/drug therapy, Humans ; Female ; Prospective Studies ; Trastuzumab/therapeutic use ; Receptor, ErbB-2 ; Lapatinib/therapeutic use ; Prognosis

Authors: Qiu J; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province 250012, P. R. China., Liu Q; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province 250012, P. R. China., Li P; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province 250012, P. R. China., Jiang Q; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province 250012, P. R. China., Chen W; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province 250012, P. R. China., Li D; Advanced Medical Research Institute, Meili Lake Translational Research Park, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, P. R. China., Li G; Advanced Medical Research Institute, Meili Lake Translational Research Park, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, P. R. China., Shan G; Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province 250012, P. R. China.

Source: Journal of medicinal chemistry [J Med Chem] 2023 Aug 10; Vol. 66 (15), pp. 10265-10272. Date of Electronic Publication: 2023 Jul 08.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE

MeSH Terms: Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/therapeutic use, Lapatinib/pharmacology ; Photosensitizing Agents/pharmacology ; Trastuzumab ; Receptor, ErbB-2/metabolism ; Ligands ; Photolysis ; Quinazolines/pharmacology ; Quinazolines/therapeutic use ; Receptor, ErbB-3/metabolism ; Cell Line, Tumor ; Drug Resistance, Neoplasm

Authors: VanSlyke JK; Department of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, Oregon, United States., Boswell BA; Department of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, Oregon, United States., Musil LS; Department of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, Oregon, United States.

Source: Investigative ophthalmology & visual science [Invest Ophthalmol Vis Sci] 2023 Jul 03; Vol. 64 (10), pp. 6.

Publication Type: Journal Article

Journal Info: Publisher: Association For Research In Vision And Ophthalmology (Arvo) Country of Publication: United States NLM ID: 7703701 Publication Model: Print Cited Medium: Internet ISSN: 1552-5783 (Electronic) Linking ISSN: 01460404 NLM ISO Abbreviation: Invest Ophthalmol Vis Sci Subsets: MEDLINE

MeSH Terms: Capsule Opacification*/metabolism , Cataract*/etiology , Cataract*/metabolism, Humans ; Lapatinib/metabolism ; Ligands ; Epithelial Cells/metabolism ; Transforming Growth Factor beta/metabolism ; Fibrosis

Authors: Qi T; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Cao Y; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Electronic address: yanguang@unc.edu.

Source: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2023 Jul 01; Vol. 186, pp. 106467. Date of Electronic Publication: 2023 May 16.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Science B.V Country of Publication: Netherlands NLM ID: 9317982 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0720 (Electronic) Linking ISSN: 09280987 NLM ISO Abbreviation: Eur J Pharm Sci Subsets: MEDLINE

MeSH Terms: Breast Neoplasms*/pathology , Quinolines*/therapeutic use, Humans ; Female ; Receptor, ErbB-2 ; Lapatinib/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use

Authors: Patnaik SK; Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education & Research, The Nilgiris, Tamilnadu, India., Swaroop AK; Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education & Research, The Nilgiris, Tamilnadu, India., Naik MR; Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education & Research, The Nilgiris, Tamilnadu, India., Selvaraj J; Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education & Research, The Nilgiris, Tamilnadu, India., Chandrasekar MJN; Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education & Research, The Nilgiris, Tamilnadu, India.; School of Life Sciences, JSS Academy of Higher Education & Research(Ooty Campus), Longwood, Mysuru Road, Ooty-643001, Tamilnadu, India.

Source: Drug research [Drug Res (Stuttg)] 2023 Jul; Vol. 73 (6), pp. 341-348. Date of Electronic Publication: 2023 Apr 17.

Publication Type: Journal Article

Journal Info: Publisher: Thieme Country of Publication: Germany NLM ID: 101602406 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2194-9387 (Electronic) Linking ISSN: 21949379 NLM ISO Abbreviation: Drug Res (Stuttg) Subsets: MEDLINE

MeSH Terms: Drug Repositioning* , Antineoplastic Agents*/pharmacology, Lapatinib/pharmacology ; Quinazolines/pharmacology ; Quinazolines/therapeutic use ; Peptides/pharmacology

Authors: Yang Y; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, No. 37, GuoXue Xiang, Chengdu, Sichuan, China.; West China Biomedical Big Data Center, Sichuan University, No. 37, GuoXue Xiang, Chengdu, Sichuan, China., Qian Z; Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China., Feng M; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, No. 37, GuoXue Xiang, Chengdu, Sichuan, China.; West China Biomedical Big Data Center, Sichuan University, No. 37, GuoXue Xiang, Chengdu, Sichuan, China., Liao W; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, No. 37, GuoXue Xiang, Chengdu, Sichuan, China.; West China Biomedical Big Data Center, Sichuan University, No. 37, GuoXue Xiang, Chengdu, Sichuan, China., Wu Q; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, No. 37, GuoXue Xiang, Chengdu, Sichuan, China.; West China Biomedical Big Data Center, Sichuan University, No. 37, GuoXue Xiang, Chengdu, Sichuan, China., Wen F; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, No. 37, GuoXue Xiang, Chengdu, Sichuan, China.; West China Biomedical Big Data Center, Sichuan University, No. 37, GuoXue Xiang, Chengdu, Sichuan, China., Li Q; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, No. 37, GuoXue Xiang, Chengdu, Sichuan, China. liqiu@scu.edu.cn.; West China Biomedical Big Data Center, Sichuan University, No. 37, GuoXue Xiang, Chengdu, Sichuan, China. liqiu@scu.edu.cn.

Source: BMC bioinformatics [BMC Bioinformatics] 2022 Oct 19; Vol. 23 (1), pp. 437. Date of Electronic Publication: 2022 Oct 19.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100965194 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2105 (Electronic) Linking ISSN: 14712105 NLM ISO Abbreviation: BMC Bioinformatics Subsets: MEDLINE

Authors: Xu Z; Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, Zhejiang, PR China., Gao Z; Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, Zhejiang, PR China., Fu H; Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, Zhejiang, PR China., Zeng Y; Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, Zhejiang, PR China., Jin Y; Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, Zhejiang, PR China., Xu B; Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, Zhejiang, PR China., Zhang Y; Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, Zhejiang, PR China., Pan Z; Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, Zhejiang, PR China., Chen X; Department of Oncology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, Zhejiang, PR China., Zhang X; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine ; Hangzhou 310003, Zhejiang, PR China., Wang X; Department of Chemotherapy, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou 310022, Zhejiang, PR China., Yan H; Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, Zhejiang, PR China., Yang X; Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, Zhejiang, PR China., Yang B; Institute of Pharmacology & Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, Zhejiang, PR China., He Q; Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, Zhejiang, PR China.; Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Hangzhou 310018, Zhejiang, PR China.; Department of Cardiology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, Zhejiang, PR China., Luo P; Center for Drug Safety Evaluation and Research of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, Zhejiang, PR China.; Department of Pharmacology and Toxicology, Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310018, PR China.

Source: Cardiovascular research [Cardiovasc Res] 2023 May 22; Vol. 119 (5), pp. 1250-1264.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Oxford Journals Country of Publication: England NLM ID: 0077427 Publication Model: Print Cited Medium: Internet ISSN: 1755-3245 (Electronic) Linking ISSN: 00086363 NLM ISO Abbreviation: Cardiovasc Res Subsets: MEDLINE

MeSH Terms: Induced Pluripotent Stem Cells*/metabolism , Heart Diseases*/chemically induced , Heart Diseases*/prevention & control , Heart Diseases*/metabolism , Breast Neoplasms*/drug therapy , Antineoplastic Agents*/toxicity, Humans ; Mice ; Rats ; Animals ; Female ; Trastuzumab/toxicity ; Trastuzumab/metabolism ; Lapatinib/adverse effects ; Lapatinib/metabolism ; Cardiotoxicity/metabolism ; Cardiotoxicity/pathology ; Endothelial Cells/metabolism ; Calcium/metabolism ; Quinazolines/adverse effects ; Receptor, ErbB-2/metabolism ; Antibodies, Monoclonal/adverse effects

Authors: Tariq M; Department of Pharmacology, Lahore Pharmacy College Lahore, Pakistan; College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. Electronic address: malikatariq05@gmail.com., Hussain N; Department of Pharmaceutical Sciences, College of Pharmacy, Al Ain University, Al Ain 64141, United Arab Emirates., Rehman K; Department of Pharmacy, The Women University, Multan, Pakistan., Akash MSH; Department of Pharmaceutical Chemistry, Government College University, Faisalabad, Pakistan., Al Haddad AHI; Chief Operations Office, Sheikh Shakhbout Medical City (SSMC), Abu Dhabi, United Arab Emirates., Said ASA; Department of Clinical Pharmacy, College of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emirates; AAU Health and Biomedical Research Center, Al Ain University, Abu Dhabi, United Arab Emirates; Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt., Fatease AA; Department of Pharmaceutics, College of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia., Alamri A; Department of Pharmaceutics, College of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia., Safhi AY; Department of Pharmaceutics, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia., Sabei FY; Department of Pharmaceutics, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia., Awadh AAA; Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Najran University, 1988, Najran 61441, Saudi Arabia., Hussain M; Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan. Electronic address: musaddique.hussain@iub.edu.pk.

Source: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 May; Vol. 161, pp. 114527. Date of Electronic Publication: 2023 Mar 15.

Publication Type: Journal Article

Journal Info: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE

MeSH Terms: Macrophages*/metabolism , Lung Neoplasms*/drug therapy , Lung Neoplasms*/prevention & control , Lung Neoplasms*/metabolism, Humans ; Lapatinib/pharmacology ; Lapatinib/metabolism ; Lapatinib/therapeutic use ; Interleukin-13/metabolism

Authors: Vacher L; Oncology Department, Centre Jean Perrin, F-63011, Clermont-Ferrand, France. Laure.VACHER@clermont.unicancer.fr.; University Clermont 1, UFR Médecine, FR-63000, Clermont-Ferrand, France. Laure.VACHER@clermont.unicancer.fr., Thivat E; Délégation Recherche Clinique & Innovation, Centre de Lutte contre le Cancer, 58 rue Montalembert, F-63000, Clermont-Ferrand, France.; Centre d'Investigation Clinique UMR 501, F-63001, Clermont-Ferrand, France.; Université Clermont Auvergne, Centre Jean Perrin, INSERM, UMR1240 Imagerie Moléculaire et Stratégies Théranostiques, FR-63000, Clermont-Ferrand, France., Poirier C; Oncology Department, Centre Jean Perrin, F-63011, Clermont-Ferrand, France., Mouret-Reynier MA; Oncology Department, Centre Jean Perrin, F-63011, Clermont-Ferrand, France.; Université Clermont Auvergne, Centre Jean Perrin, INSERM, UMR1240 Imagerie Moléculaire et Stratégies Théranostiques, FR-63000, Clermont-Ferrand, France., Chollet P; Oncology Department, Centre Jean Perrin, F-63011, Clermont-Ferrand, France.; Délégation Recherche Clinique & Innovation, Centre de Lutte contre le Cancer, 58 rue Montalembert, F-63000, Clermont-Ferrand, France.; Centre d'Investigation Clinique UMR 501, F-63001, Clermont-Ferrand, France., Devaud H; Oncology Department, Centre Jean Perrin, F-63011, Clermont-Ferrand, France., Dubray-Longeras P; Oncology Department, Centre Jean Perrin, F-63011, Clermont-Ferrand, France.; Université Clermont Auvergne, Centre Jean Perrin, INSERM, UMR1240 Imagerie Moléculaire et Stratégies Théranostiques, FR-63000, Clermont-Ferrand, France., Kwiatkowski F; Délégation Recherche Clinique & Innovation, Centre de Lutte contre le Cancer, 58 rue Montalembert, F-63000, Clermont-Ferrand, France.; Centre d'Investigation Clinique UMR 501, F-63001, Clermont-Ferrand, France., Durando X; Oncology Department, Centre Jean Perrin, F-63011, Clermont-Ferrand, France.; University Clermont 1, UFR Médecine, FR-63000, Clermont-Ferrand, France.; Délégation Recherche Clinique & Innovation, Centre de Lutte contre le Cancer, 58 rue Montalembert, F-63000, Clermont-Ferrand, France.; Centre d'Investigation Clinique UMR 501, F-63001, Clermont-Ferrand, France.; Université Clermont Auvergne, Centre Jean Perrin, INSERM, UMR1240 Imagerie Moléculaire et Stratégies Théranostiques, FR-63000, Clermont-Ferrand, France., van Praagh-Doreau I; Oncology Department, Centre Jean Perrin, F-63011, Clermont-Ferrand, France.; Université Clermont Auvergne, Centre Jean Perrin, INSERM, UMR1240 Imagerie Moléculaire et Stratégies Théranostiques, FR-63000, Clermont-Ferrand, France., Chevrier R; Pharmacy Department, Centre Jean Perrin, F-63011, Clermont-Ferrand, France.

Source: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2020 Jul; Vol. 28 (7), pp. 3313-3322. Date of Electronic Publication: 2019 Nov 22.

Publication Type: Journal Article

Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE

Authors: Huijberts SCFA; Department of Medical Oncology and Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. s.huijberts@nki.nl., van Geel RMJM; Department of Medical Oncology and Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, The Netherlands.; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands., van Brummelen EMJ; Department of Medical Oncology and Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.; Centre for Human Drug Research, Leiden, The Netherlands., Opdam FL; Department of Medical Oncology and Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. f.opdam@nki.nl., Marchetti S; Department of Medical Oncology and Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands., Steeghs N; Department of Medical Oncology and Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands., Pulleman S; Department of Medical Oncology and Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands., Thijssen B; Department of Pharmacy, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Rosing H; Department of Pharmacy, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Monkhorst K; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Huitema ADR; Department of Pharmacy, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands., Beijnen JH; Department of Pharmacy, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Utrecht University, Utrecht, The Netherlands., Bernards R; Division of Molecular Carcinogenesis, Oncode Institute and The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schellens JHM; Utrecht University, Utrecht, The Netherlands.

Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2020 May; Vol. 85 (5), pp. 917-930. Date of Electronic Publication: 2020 Apr 09.

Publication Type: Clinical Trial; Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE